Epidemiological and economical burden of cholestatic liver disease

Bregje Mol1,2, Ellen Werner3, Emma L Culver4

  • 1Department of Gastroenterology and Hepatology, Amsterdam University Medical Centre, Amsterdam, The Netherlands.

PubMed

Insights

Primary sclerosing cholangitis, primary biliary cholangitis, and IgG4-related cholangitis are increasingly important liver diseases. Understanding their epidemiology and patient impact is crucial as they rise in prevalence.

Area of Science:

  • Hepatology and Gastroenterology
  • Rare Diseases
  • Immunology

Background:

  • Cholestatic liver diseases, including primary sclerosing cholangitis (PSC), primary biliary cholangitis (PBC), and IgG4-related cholangitis (IgG4-AC), are gaining clinical significance.
  • Their incidence is rising, contrasting with declining viral hepatitis rates, making them a growing focus in hepatology.
  • These conditions are now a leading reason for liver transplantation in Western nations.

Purpose of the Study:

  • To offer a comprehensive review of the epidemiology of PSC, PBC, and IgG4-AC.
  • To examine the impact of these cholestatic liver diseases on health-related quality of life.
  • To assess the economic burden associated with PSC, PBC, and IgG4-AC.

Main Methods:

  • Systematic literature review of epidemiological data.
  • Analysis of studies reporting on quality of life in patients with PSC, PBC, and IgG4-AC.
  • Review of economic evaluations and cost-of-illness studies.

Main Results:

  • Cholestatic liver diseases represent a growing public health concern with increasing prevalence.
  • Patients with PSC, PBC, and IgG4-AC experience significant decrements in quality of life.
  • These diseases impose a substantial economic burden on healthcare systems and society.

Conclusions:

  • PSC, PBC, and IgG4-AC require greater attention due to their rising incidence and impact.
  • Further research into effective management strategies and patient support is warranted.
  • Addressing the quality of life and economic consequences is essential for comprehensive patient care.

Related Concept Videos

Diseases of the Liver and Gallbladder01:26

Diseases of the Liver and Gallbladder

Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
374
Cholesterol: Significance and Regulation01:29

Cholesterol: Significance and Regulation

Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
462
Chronic Pancreatitis II: Collaborative Care01:29

Chronic Pancreatitis II: Collaborative Care

The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
50
Chronic Bowel Disorders: Introduction01:17

Chronic Bowel Disorders: Introduction

Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
345
Hepatic Drug Excretion: Influencing Factors01:16

Hepatic Drug Excretion: Influencing Factors

The biliary system of the liver, crucial for bile secretion and drug excretion, comprises intrahepatic bile ducts that merge to form the common hepatic duct. This duct, carrying hepatic bile, combines with the cystic duct, draining the gallbladder and forming the common bile duct, which empties into the duodenum. Bile, produced by hepatic cells lining the bile canaliculi, is composed primarily of water, bile salts, pigments, electrolytes, and lesser amounts of cholesterol and fatty acids. Bile...
64
Gross Anatomy of the Liver01:17

Gross Anatomy of the Liver

The liver, the largest gland within the human body, is a firm and reddish-brown organ. This wedge-shaped structure weighs approximately 1.5 kg and occupies a significant portion of the right hypochondriac and epigastric regions. It extends more to the right of the body's midline than to the left.
Located under the diaphragm, the liver is almost entirely ensconced within the rib cage, providing it with substantial protection. Except for the superior most bare area, the liver's surface is...
254